Nuvei Corporation

NASDAQ:NVEI

33.99 (USD) • At close November 15, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12017 Q4
Revenue 357.618345.407333.612321.517304.852307.026256.498220.339197.146211.294214.544211.875183.932178.239149.895115.88193.59982.56883.23979.32770.75250.45347.86933.694
Cost of Revenue 72.051106.022101.10658.73455.6553.92654.59650.16638.36335.9846.91649.11538.33233.12428.97923.51917.00713.56115.16813.07512.1738.1417.7556.52
Gross Profit 285.567239.385232.506262.783249.202253.1201.902170.173158.783175.314167.628162.76145.6145.115120.91692.36276.59269.00768.07166.25258.57942.31240.11427.174
Gross Profit Ratio 0.7990.6930.6970.8170.8170.8240.7870.7720.8050.830.7810.7680.7920.8140.8070.7970.8180.8360.8180.8350.8280.8390.8380.806
Reseach & Development Expenses 00000000000000010.8610006.2430000
General & Administrative Expenses 200.0034.904193.271180.137180.738185.83166.96297.99694.77790.58593.96485.49950.61139.50636.66629.07926.60218.64320.6718.92831.01511.9081.4337.991
Selling & Marketing Expenses 072.315-6.6663.43259.72160.26838.29927.65228.0829.75727.79828.42331.86736.28826.57318.10417.39615.49816.41316.99817.45216.94615.5219.413
SG&A 200.003183.583186.611180.137180.738221.755166.962148.465122.857120.342121.762113.92282.47875.79463.23947.18343.99834.14137.08335.92648.46728.85428.49517.404
Other Expenses 39.105000000026.26927.04626.44325.93823.15220.7420.99818.4116.93117.0217.31317.04115.3579.49408.347
Operating Expenses 239.108228.492186.611216.435217.282221.755194.618148.465149.126147.388148.205139.86105.6396.53484.23765.59360.92951.16154.39652.96763.82438.34836.34725.751
Operating Income 46.45948.94745.89546.34831.9231.3457.2847.24113.78828.80920.81621.83939.52449.24534.8619.17115.19415.7413.20510.887-4.111.3372.2560.588
Operating Income Ratio 0.130.1420.1380.1440.1050.1020.0280.0330.070.1360.0970.1030.2150.2760.2330.1650.1620.1910.1590.137-0.0580.0260.0470.017
Total Other Income Expenses Net -21.31-37.504-38.216-32.64-40.373-17.242-11.695-6.614.61112.105-7.69-1.965-5.32-4.211-2.011-2.266-90.336-4.348-75.632-18.124-60.537-3.313-3.396-5.963
Income Before Tax 25.14911.4432.05313.708-8.45314.103-4.41115.09818.39940.91413.12619.87434.20445.03432.84921.685-74.36414.523-62.427-7.237-64.647-1.976-1.14-5.375
Income Before Tax Ratio 0.070.0330.0060.043-0.0280.046-0.0170.0690.0930.1940.0610.0940.1860.2530.2190.187-0.7940.176-0.75-0.091-0.914-0.039-0.024-0.16
Income Tax Expense 7.9146.0956.838-0.3889.6672.4863.8785.7465.3935.8318.6127.5356.2026.125.059-0.8923.5050.558-0.084-4.161.049-0.5750.794-2.027
Net Income 15.3643.465-6.83211.834-19.8149.923-9.7788.0411.7133.9794.51410.80826.84137.8326.81422.577-77.86913.965-62.593-3.077-65.696-1.401-0.431-3.348
Net Income Ratio 0.0430.01-0.020.037-0.0650.032-0.0380.0360.0590.1610.0210.0510.1460.2120.1790.195-0.8320.169-0.752-0.039-0.929-0.028-0.009-0.099
EPS 0.110.025-0.0490.087-0.140.072-0.070.0570.0830.240.0320.0860.190.270.190.16-0.590.1-0.5-0.024-0.52-0.011-0.003-0.027
EPS Diluted 0.10.024-0.0490.086-0.140.07-0.070.0560.0820.230.0310.0840.190.260.190.16-0.590.1-0.5-0.024-0.52-0.011-0.003-0.027
EBITDA 93.29993.85668.56278.40757.40680.39341.14528.97547.72655.85545.6950.64262.06268.61962.97746.436-15.09438.023-24.08937.185-29.66710.70111.6195.162
EBITDA Ratio 0.2610.2720.2470.2110.2330.2220.1550.1320.2030.3050.2070.2330.3460.3940.3910.401-0.2670.3690.2490.351-0.3620.2720.2430.21